Bacterial vaginosis: identifying research gaps proceedings of a workshop sponsored by DHHS/NIH/NIAID
- PMID: 21068695
- PMCID: PMC3137891
- DOI: 10.1097/OLQ.0b013e3181fbbc95
Bacterial vaginosis: identifying research gaps proceedings of a workshop sponsored by DHHS/NIH/NIAID
Abstract
The microbiota of the human vagina can affect the health of women, their fetuses, and newborns. Bacterial vaginosis (BV) is the most prevalent form of vaginal infection in women of reproductive age, affecting 8% to 23%, and is the most common etiology of vaginal symptoms prompting women to seek medical care. While traditional cultivation has identified numerous BV-associated bacteria involved in these processes, recent advances in molecular biology have facilitated the detection and identification of bacteria without cultivation, some of which have not previously been described or well characterized. A more complete understanding of vaginal microbial populations resulting from the adoption of molecular tools may lead to better strategies to maintain healthy vaginal microbial communities-thus enhancing women's health-and will create opportunities to explore the role of novel bacteria in reproductive tract diseases. On November 19-20, 2008, the NIH convened a workshop of experts in the field of research and clinical practice related to BV in order to discuss how these new advances should be interpreted and applied to research in progress and collaborations between relevant disciplines. This paper summarizes the presentations of this workshop and outlines general recommendations arising from the related discussions. Future studies of BV and its associated adverse outcomes should determine if specific combinations of organisms are more pathogenic than others, and causally associated with different adverse events. Moreover, determination of causality will depend not only on more precise categorization of the vaginal microbiota, but also on variations in the host environment that may be associated with changes in bacterial communities over time. In this report, we offer suggestions and recommendations that we hope will facilitate conduct of consistent approaches to collaborative efforts towards advancing our understanding of the vaginal microbiota and its impact on human health.
Figures



Similar articles
-
Molecular analysis of the diversity of vaginal microbiota associated with bacterial vaginosis.BMC Genomics. 2010 Sep 7;11:488. doi: 10.1186/1471-2164-11-488. BMC Genomics. 2010. PMID: 20819230 Free PMC article.
-
Molecular Identification of Cervical Microbes in HIV-Negative and HIV-Positive Women in an African Setting Using a Customized Bacterial Vaginosis Microbial DNA Quantitative PCR (qPCR) Array.Microbiol Spectr. 2022 Jun 29;10(3):e0222921. doi: 10.1128/spectrum.02229-21. Epub 2022 Jun 1. Microbiol Spectr. 2022. PMID: 35647888 Free PMC article.
-
Temporal Changes in Vaginal Microbiota and Genital Tract Cytokines Among South African Women Treated for Bacterial Vaginosis.Front Immunol. 2021 Sep 14;12:730986. doi: 10.3389/fimmu.2021.730986. eCollection 2021. Front Immunol. 2021. PMID: 34594336 Free PMC article.
-
Vaginosis. Vaginal microbiota.Enferm Infecc Microbiol Clin (Engl Ed). 2019 Nov;37(9):592-601. doi: 10.1016/j.eimc.2018.11.009. Epub 2018 Dec 26. Enferm Infecc Microbiol Clin (Engl Ed). 2019. PMID: 30594321 Review. English, Spanish.
-
Bacterial Vaginosis: Effects on reproduction and its therapeutics.J Gynecol Obstet Hum Reprod. 2021 Nov;50(9):102174. doi: 10.1016/j.jogoh.2021.102174. Epub 2021 Jun 2. J Gynecol Obstet Hum Reprod. 2021. PMID: 34087449 Review.
Cited by
-
Genome Sequences of 11 Human Vaginal Actinobacteria Strains.Genome Announc. 2016 Sep 29;4(5):e00887-16. doi: 10.1128/genomeA.00887-16. Genome Announc. 2016. PMID: 27688328 Free PMC article.
-
Length-Heterogeneity Polymerase Chain Reaction as a Diagnostic Tool for Bacterial Vaginosis.Chin Med J (Engl). 2018 Sep 20;131(18):2242-2243. doi: 10.4103/0366-6999.240801. Chin Med J (Engl). 2018. PMID: 30203804 Free PMC article. No abstract available.
-
A behavioural intervention to reduce persistence of bacterial vaginosis among women who report sex with women: results of a randomised trial.Sex Transm Infect. 2011 Aug;87(5):399-405. doi: 10.1136/sti.2011.049213. Epub 2011 Jun 8. Sex Transm Infect. 2011. PMID: 21653935 Free PMC article. Clinical Trial.
-
Clinical features of bacterial vaginosis in a murine model of vaginal infection with Gardnerella vaginalis.PLoS One. 2013;8(3):e59539. doi: 10.1371/journal.pone.0059539. Epub 2013 Mar 19. PLoS One. 2013. PMID: 23527214 Free PMC article.
-
Predictive value of the composition of the vaginal microbiota in bacterial vaginosis, a dynamic study to identify recurrence-related flora.Sci Rep. 2016 Jun 2;6:26674. doi: 10.1038/srep26674. Sci Rep. 2016. PMID: 27253522 Free PMC article. Clinical Trial.
References
-
- Sobel J. Current Concepts: Vaginitis. N Engl J Med. 1997;337:1896–903. - PubMed
-
- Olmsted SS, Meyn LA, Rohan LC, Hillier SL. Glycosidase and proteinase activity of anaerobic gram-negative bacteria isolated from women with bacterial vaginosis. Sex Transm Dis. 2003;30:257–61. - PubMed
-
- Hillier SL, Marrazzo JM, Holmes KK. Bacterial vaginosis. In: Holmes KK, Sparling PF, Mardh P-A, et al., editors. Sexually Transmitted Diseases. 4th ed McGraw-Hill; New York: 2008. pp. 737–68.
-
- Hawes SE, Hillier SL, Benedetti J, et al. Hydrogen peroxide-producing lactobacilli and acquisition of vaginal infections. J Infect Dis. 1996;174:1058–63. - PubMed
-
- Barbone F, Austin H, Louv WC, Alexander WJ. A follow-up study of methods of contraception, sexual activity, and rates of trichomoniasis, candidiasis, and bacterial vaginosis. Am J Obstet Gynecol. 1990;163:510–4. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical